VistaGen Therapeutics, Inc. (VSTA) Poised to Revolutionize Clinical Trials and Pioneer hPSC Technology for Drug Rescue
Biotechnology company VistaGen Therapeutics is blazing trails with advances in pluripotent stem cell technology, operating on the belief that “Better Cells Make Better Medicine.” Human Clinical Trials in a Test Tube is the company’s versatile human pluripotent stem cell (hPSC) technology platform, which has been developed to give clinically relevant predictions of the potential toxicity of promising new drug candidates long before they ever reach the human testing stage. VistaGen’s hPSC-based bioassay systems much more closely approximate human biology than the conventional animal testing and other nonclinical techniques and technologies currently being used in drug development. VistaGen has expertise in…